Cellusion Inc.
- Medical Engineering & Biotechnology
Corporate Number｜7010901035500
Cellusion aim to solve unmet medical needs based on "patient-centricity" by creating innovative regenerative medicine using iPS cells from Japan. Currently, corneal transplantation requires highly skilled specialists and corneal donors, so many patients are waiting for the treatment that is not available worldwide. We aim to contribute to patients with corneal blindness around the world by our proprietary technology, which is a minimally invasive cell therapy with corneal endothelial cells derived from iPS cells.
